• 대한간호학회지
• /
• 제50권2호
• /
• pp.271-285
• /
• 2020

Purpose: This study examined the effects of a physical activity promoting program based on the Information-Motivation-Behavioral Skills (IMB) model on physical activity and health outcomes among obese older adults with knee osteoarthritis. Methods: This study utilized a randomized controlled trial with a convenience sample of 75 obese older adults with knee osteoarthritis in a university hospital. The older adults in the intervention group participated in a 12-week program involving weekly group sessions and monitoring calls with education booklets and video clips for exercise dances, while those in the control group received an usual care. Outcomes were measured using self-report questionnaires, anthropometrics, and blood analyses. The intervention effects were analyzed using Mann-Whitney U test and ANCOVA. Results: The mean age of participants was 74.9 years with 84.0% women. The intervention group at 12 weeks showed significantly greater improvements in self-efficacy for physical activity (F=81.92, p<.001), physical activity amounts (Z=-2.21, p=.044), knee joint function (F=15.88, p<.001), and health-related quality of life (F=14.89, p<.001) compared to the control group. Among obese-metabolic outcomes, the intervention group at 12 weeks showed a significant decrease in visceral fat mass (F=7.57, p=.008) and improvement in high-density level cholesterol (F=9.51, p=.003) compared to the control group. Conclusion: Study findings support the need for an IMB based physical activity program for promoting physical activity, knee function and health outcomes in obese older adults with knee osteoarthritis. Longitudinal studies are warranted to confirm the persistence of obese-metabolic effects in clinical settings.

• Safety and Health at Work
• /
• 제3권4호
• /
• pp.287-293
• /
• 2012

Objectives: Metabolic syndrome has received attention as a risk factor for cardiovascular disease, with particular importance attached to visceral fat accumulation, which is associated with lifestyle-related diseases and is strongly correlated with waist circumference. In this study, our aim is to propose waist circumference cut-off values that can be used as a marker for fatty liver based on a sample of workers receiving health checkups in Japan. Methods: This study was conducted in a total of 21,866 workers who underwent periodic health checkups between January 2007 and December 2007. The mean age of the subjects was 47.4 years for men (standard deviation [SD]: 8.0) and 44.7 years for women (SD: 6.9). Evaluation included abdominal ultrasound and measurement of waist circumference, body mass index, fasting blood glucose, triglycerides, high-density lipoprotein cholesterol, and blood pressure. Results: Based on receiver operating characteristic curve analysis, the optimal waist circumference cut-off values were shown as 85.0 cm (sensitivity 0.72, specificity 0.69) for men and 80.0 cm (sensitivity 0.75, specificity 0.78) for women. Conclusion: Abdominal ultrasound is the most efficient means of diagnosing fatty liver, but this examination seldom occurs because the test is not routinely performed at workers' health checkups. In people found to have a high risk of fatty liver, recommendations can be made for abdominal ultrasound based on the waist circumference cut-off values obtained in this study. That is, waist circumference can be used in high risk individuals as an effective marker for early detection of fatty liver.

• 대한한방내과학회지
• /
• 제43권2호
• /
• pp.184-190
• /
• 2022

Objectives: This study aims to report the clinical efficacy of Korean medical treatment of a patient with nonalcoholic fatty liver disease accompanied by obesity and dyslipidemia. Methods: A 52-year-old man with nonalcoholic fatty liver disease, obesity, and dyslipidemia was treated with Saenggangunbi-tang extract from November 3, 2021 to January 8, 2022. During the treatment period, the patient also undertook exercise and maintained a hypocaloric diet to reduce body weight. Changes were observed in the patient's symptoms, laboratory findings, such as liver enzymes and lipid profiles, and bioelectrical impedance analyzer results. Results: After taking Saenggangunbi-tang extract for approximately two months, with concomitant adjustments to exercise and diet, the serum levels of liver enzymes and triglyceride were decreased and the patient's body weight, body mass index, hepatic steatosis index, and visceral fat area were also reduced. In addition, symptoms including fatigue and dyspepsia improved. Conclusion: This study suggests that Saenggangunbi-tang extract with exercise and a regulated diet could be a helpful treatment strategy for managing nonalcoholic fatty liver disease with metabolic disorders.

• 대한한방내과학회지
• /
• 제42권2호
• /
• pp.207-214
• /
• 2021

Objectives: This study aimed to identify whether herbal medicine improves the clinical symptoms and abnormal blood tests of a patient with fatty liver accompanied by hypertriglyceridemia. Methods: A 44-year-old man with fatty liver and hypertriglyceridemia was prescribed Saenggangunbi-tang from July 20, 2020, to November 11, 2020, to reduce fatigue and to improve laboratory findings, such as liver enzymes and the lipid profile. We observed changes in symptoms, serum levels of liver enzymes, and the lipid profile during about 4-month treatment. We also recorded changes in the bioelectrical impedance analyzer findings during that time. Results: In this case study, an approximately 4-month treatment with Saenggangunbi-tang led to considerable improvement in laboratory findings and visceral fat area. In particular, the patient experienced a noticeable decrease in triglyceride levels compared with the baseline parameters of the first visit. In addition, no side effects-including weight gain and liver enzyme increases-were observed during treatment. Conclusion: This study suggests that appropriately prescribed herbal medicine is a therapeutic option to manage fatty liver combined with hypertriglyceridemia.

• Clinical and Experimental Pediatrics
• /
• 제46권8호
• /
• pp.795-802
• /
• 2003

목 적 : 지방조직에 존재하는 OB 유전자에서 전사된 호르몬인 leptin은 여러 가지 생리적 요인이나, 호르몬에 의해서 영향을 받는다. Leptin의 발현에 대한 호르몬에 대한 연구가 많은 동물 실험들을 상대로 시도되고 있으나 사람에서 OB 유전자와 leptin 분비를 조절하는 호르몬의 영향 및 상호작용에 대해서는 아직 명확히 밝혀져 있지 않다. 본 연구는 사람의 복강에서 추출한 조직배양에서 OB 유전자와 leptin 분비를 조절하는 호르몬의 영향 및 상호작용에 대해서 알아보고자 하였다. 방 법 : 복부수술을 위하여 입원한 환자 7명을 대상으로 복강 내 지방조직을 절제하여 배양액에 호르몬을 첨가하지 않은 상태와 배양액에 인슐린, dexamethasone 및, 성장호르몬을 단독으로 첨가하거나, 인슐린과 dexamethasone을 동시에 첨가하거나, 인슐린과 dexamethasone과 성장호르몬을 같이 첨가한 상태에서 48시간 배양한 후 RNA를 추출하여 경쟁적 역전사 중합반응(competitive RT-PCR)을 시행하여 OB 유전자의 발현을 측정하고, human leptin IRMA Kit를 사용하여 지방조직에서 분비되는 배양액 내 leptin 양을 측정하였다. 결 과 : 인슐린은 단독으로는 OB 유전자 발현과 leptin 분비에는 영향을 미치지 못하였다. Dexamethasone은 OB 유전자의 발현과 leptin 분비를 증가시켰는데, 48시간 배양 후에 대조군에 비해 의미있게 증가하였다. 인슐린과 dexamethasone을 같이 배양시에는 OB 유전자 발현에 있어서는 의미있는 차이는 없었으나, leptin 분비는 48시간 배양 후 대조군에 비해 의미있게 증가하였다. 또한 성장호르몬 단독으로는 OB 유전자의 발현에 영향을 미치지는 못하나, 인슐린, dexamethasone, 성장호르몬을 같이 배양시에 인슐린과 dexamethasone의 OB 유전자 발현과 leptin 분비증가 능력을 억제시켰다. 결 론 : 인슐린 단독으로는 leptin 분비를 증가시키지 못하나, dexamethasone에 의해 상승작용이 나타나고, 이는 dexamethasone이 OB 유전자 발현을 증가시킨 후에 인슐린이 세포질내에서의 leptin 분비를 증가시킨다고 추정할 수 있다. 성장호르몬의 억제효과는 성장호르몬이 인슐린이나 dexamethasone에 대한 지방조직의 반응성을 변화시킴으로써 간접적으로 leptin의 발현을 조절할 것으로 추정되며, dexamethasone이 OB 유전자 발현을 증가시킨 후에 인슐린이 세포질 내에서의 leptin 분비를 증가시킨다는 것에 대한 연구가 더 필요하리라 사료된다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제22권4호
• /
• pp.576-583
• /
• 2009

G protein-coupled receptor 43 (GPR43) is a newly-discovered short-chain free fatty acid receptor and its functions remain to be defined. The objective of this study was to investigate the function of GPR43 on lipolysis. We successfully cloned the GPR43 gene from the pig (EU122439), and measured the level of GPR43 mRNA in different tissues and primary pig adipocytes. The expression level of GPR43 mRNA was higher in adipose tissue and increased gradually with adipocyte differentiation. Then we examined GPR43 mRNA level in different types, growth-stages and various regions of adipose tissue of pigs. The results showed that the expression level of GPR43 mRNA was significantly higher in adipose tissue of obese pigs than in lean pigs, and the expression level also gradually increased as age increased. We further found that the abundance of GPR43 mRNA level increased more in subcutaneous fat than visceral fat. Thereafter, we studied the correlation between GPR43 and lipid metabolism-related genes in adipose tissue and primary pig adipocytes. GPR43 gene had significant negative correlation with hormone-sensitive lipase gene (HSL, r = -0.881, p<0.01) and triacylglycerol hydrolase gene (TGH, r = -0.848, p<0.01) in adipose tissue, and had positive correlation with peroxisome proliferator-activated receptor $\gamma$ gene ($PPAR_{\gamma}$, r = 0.809, p<0.01) and lipoprotein lipase gene (LPL, r = 0.847, p<0.01) in adipocytes. In addition, we fed different concentrations of docosahexaenoic acid (DHA) to mice, and analyzed expression level changes of GPR43, HSL and TGH in adipose. The results showed that DHA down-regulated GPR43 and up-regulated HSL and TGH mRNA levels; GPR43 also had significant negative correlation with HSL (low: r = -0.762, p<0.01; high: r = -0.838, p<0.01) and TGH (low: r = -0.736, p<0.01; high: r = -0.586, p<0.01). Our results suggested that GPR43 is a potential factor which regulates lipolysis in adipose tissue, and DHA as a receptor of GPR43 might promote lipolysis through down-regulating the expression of GPR43 mRNA.

• 한방재활의학과학회지
• /
• 제21권1호
• /
• pp.1-22
• /
• 2011

Objectives : This study was undertaken to verify the effects of Wolbigachul-tang1(WBCEx1) on obesity using high fat diet-induced male mice and to investigate the molecular mechanisms involved. Methods : 8-week old C57BL/6 mice were divided into 5 groups; lean control, obese control, WBCEx1, 2, 3. After mice were treated with WBCEx1(water extract), 2(30% ethanol extract), 3(water extract; Ephedra sinica Stapf., Gypsum fibrosum) for 12 weeks, body weight gain, feeding efficiency ratio, plasma lipid and glucose metabolism, the messenger RNA(mRNA) expression of peroxisome proliferator activated receptor(PPAR)$\alpha$ target genes were measured. In addition, $PPAR{\alpha}$ target gene expression was examined in liver, white adipose tissue and skeletal muscle. Results : 1. WBCEx1-treated mice had significantly lower body weight gain and feeding efficiency ratio. 2. Consistent with the effects on body weight gain, WBCEx1 decreased the weights of epididymal and retroperitoneal white adipose tissue, inguinal subcutaneous adipose tissue, and brown adipose tissue. 3. WBCEx1 significantly decreased plasma triglyceride and total cholesterol levels. 4. The size of adipocytes were significantly decreased by WBCEx1, whereas the adipocyte number per unit area was increased. Hepatic lipid accumulation was decreased by WBCEx1. 5. WBCEx1 did not affect the mRNA expression of $PPAR{\alpha}$ target genes in liver, adipose tissue, and skeletal muscle. 6. Plasma asparate aminotransferase(AST), alanine aminotransferase(ALT), blood urea nitrogen(BUN) and creatine concentrations were in the physiological range. Liver and kidney weights were significantly lower following WBCEx treatment compared with obese controls, indicating that WBCEx does not show any toxic effects on liver and kidney. Conclusions : These results suggest that WBCEx1-induced body weight reduction is associated with appetite control and mediated by a mechanism other than the activation of $PPAR{\alpha}$.

• 대한지역사회영양학회지
• /
• 제24권3호
• /
• pp.245-256
• /
• 2019

Objectives: Although the number of laboratory workers is constantly increasing every year, few studies have been conducted on the health and nutritional status of these research workers. This study determined the health status of laboratory workers by analyzing their anthropometric indices, dietary life, vitamin D status and blood clinical indices. Methods: The subjects consisted of 100 female laboratory workers. This study investigated their diet, anthropometric indices, vitamin D status and blood clinical indices. The subjects were divided into two groups according to their duration of working in a laboratory (<1 year, $${\geq}_-1year$$). Results: The average age and body mass index (BMI) of subjects were 23.18 years and $21.51kg/m^2$, respectively Those subjects with over 1 year employment ($${\geq}_-1year$$) had a significantly higher waist-hip ratio than that of the subjects with the less than 1 year employment (<1 year). The mean serum vitamin D level of all the subjects was 10.04 ng/mL, which is close to a level of vitamin D deficiency. There was a significantly higher average intake of calories in the over 1 year employment group as compared to that of the less than 1 year employment group. The frequency of eating sweet snacks was significantly higher for the over 1 year employment group. The correlation analysis showed a significant positive correlation between the serum 25-(OH)-vitamin D level and the time of exposure to sunlight, while dietary intake of vitamin D did not show correlation with the serum 25-(OH)-vitamin D level. However, the serum 25-(OH)-vitamin D level was also negatively correlated with both the percentage of body fat and visceral fat. Conclusions: Laboratory workers are a very high risk group in terms of their nutritional status of vitamin D. Therefore, they need greater time of exposure to sunlight as well as increasing their dietary consumption of vitamin D. In addition, it is important for laboratory worker to practice regular and balanced dietary habits in order to maintain a healthy life.

• 정보처리학회논문지:컴퓨터 및 통신 시스템
• /
• 제12권3호
• /
• pp.119-126
• /
• 2023

근감소증은 국내는 2021년 질병으로 분류되었을 만큼 잘 알려져 있지 않지만 고령화사회에 진입한 선진국에서는 사회적 문제로 인식하고 있다. 근감소증 진단은 유럽노인근감소증 진단그룹(EWGSOP)과 아시아근감소증진단그룹(AWGS)에서 제시하는 국제표준지침을 따른다. 최근 진단방법으로 절대적 근육량 이외에 신체수행평가로 보행속도 측정과 일어서기 검사 등을 통하여 근육 기능을 함께 측정할 것을 권고하고 있다. 근육량을 측정하기 위한 대표적인 방법으로 DEXA를 이용한 체성분 분석 방법이 임상에서 정식으로 실시하고 있다. 또한 MRI 또는 CT의 복부 영상을 이용하여 근육량을 측정하는 다양한 연구가 활발하게 진행되고 있다. 따라서 본 논문에서는 근감소증 진단을 위해서 비교적 짧은 촬영시간을 갖는 CT의 복부영상기반으로 AI 영상 분할 모델을 개발하고 다기관 검증한 내용을 기술한다. 우리는 CT 영상 중에 요추의 L3 영역을 분류하여 피하지방, 내장지방, 근육을 자동으로 분할할 수 있는 인공지능 모델을 U-Net 모델을 사용하여 개발하였다. 또한 모델의 성능평가를 위해서 분할영역의 IOU(Intersection over Union)를 계산하여 내부검증을 진행했으며, 타 병원의 데이터를 활용하여 동일한 IOU 방법으로 외부검증을 진행한 결과를 보인다. 검증 결과를 토대로 문제점과 해결방안에 대해서 검증하고 보완하고자 했다.

• 대한한방부인과학회지
• /
• 제37권1호
• /
• pp.75-88
• /
• 2024

Objectives: This study aimed to identify the current use of Korean medicine for obesity and its effect for women in climacteric period. Methods: We studied women aged 45-55 who visited Daejeon Korean medicine Hospital of Daejeon University to lose body weight from January 1, 2021 to December 31, 2022 via an analysis of the medical records. The treatment duration was continuous for more than 2 weeks, and a body composition was measured by Inbody 770 at 2 to 4 weeks after the first visit. Results: 28 patients were finally selected and their average age was 49.32±3.38 years. Based on the body mass index (BMI) classification, 19 were in the 1st obesity group, 5 in the 2nd obesity group, 3 in the overweight group and 1 in the normal group. Patients usually complained comcomitant symptoms, and the symptoms of menopausal disorder was the most frequent. The average treatment duration was 3.68±0.67 weeks and the average treatment frequency was 3.93±0.98 times. All patients took herbal medicines Gambi-tang and 23 took modified fasting therapy including Gamro-su. 14 were treated by whole body far-infrared therapy and 6 were gotten partial obesity treatment. Among patients treated for accompanying symptoms, menopausal disorders were the most common (35.71%), and herbal medicine such as Gamisoyou-san, Hominis Placenta Pharmacopuncture, moxibustion, and cupping were used. After treatment, on average, body composition changed significantly; body weight 3.28±1.82 kg, BMI 1.36±1.04 kg/m², body fat 1.70±1.67 kg, skeletal muscle mass 0.81±0.91 kg, abdominal circumference 2.04±2.6 cm, and visceral fat area 8.91±12.83 cm². Conclusions: We analyzed general characteristics, BMI distribution, types of Korean medicine treatment and change of body composition. This study could be used as reference to provide practical data of treatment for obese women in climacteric period.